Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 05:59:52 Page View：58

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dewpoint Therapeutics lays off staff after losing partnerships
Next article： Cancer drug shortages should be causing more outrage

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

eGenesis tests gene

Agene-editedYucatanminipigcreatedbyeGenesis.CourtesyLizLinder/eGenesisForthreedaysinDecember,anICUro

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

The surgeon had a dilemma only a Nazi medical text could resolve

GermantroopsandartilleryparadethroughthestreetsofVienna,afterHitlerhadenteredthecity,March1938.Londo

Wikipedia

focus

explore

The surgeon had a dilemma only a Nazi medical text could resolve